Share Twitter LinkedIn Facebook Email John P. Fruehauf, MD, UC Irvine Health, Axillary Dissection in Stage 2 or 3 Melanoma | No Benefit from Taking Lymph Nodes Out
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read
